Key result
Anti-CCP antibodies demonstrate high specificity for diagnosing rheumatoid arthritis and may help predict disease persistence and radiographic joint damage, though their sensitivity in early arthritis remains debated.
Why the study?
Does Anti-CCP testing improve diagnostic accuracy and prognostic evaluation in patients with rheumatoid arthritis compared to rheumatoid factor?
Does Anti-CCP testing improve diagnostic accuracy and prognostic evaluation in patients with rheumatoid arthritis compared to rheumatoid factor?
Anti-CCP antibodies offer high specificity for diagnosing rheumatoid arthritis and provide valuable prognostic information for predicting erosive disease, especially in RF-negative patients.
Answers are grounded in this paper and cite their sources.
May support Anti-CCP testing for RA specificity and erosive prognosis in RF-negative patients; leaves open early sensitivity and comparative utility versus RF.
There is strong evidence that the determination of autoantibodies against filaggrine is a very useful tool for the diagnosis of rheumatoid arthritis (RA). Anti-cyclic citrullinated peptide antibodies (Anti-CCP)-ELISA appear to be the most efficient test among those available for the detection of antifilaggrine autoantibodies, as it has the best diagnostic accuracy for the diagnosis of RA. Furthermore, the anti-CCP-ELISA determination in early arthritis is a good predictor of disease persistence and radiographic joint damage. The positivity of Anti-CCP some years before the onset of the RA and the high concentration of autoantibodies in synovial fluid suggest a possible pathogenetic role of citrullination. However, at present, it is unclear whether anti-CCP antibodies have a better diagnostic performance than rheumatoid factor in recent onset synovitis and if they confer any additional value to the prognostic evaluation obtained with validated predictors of outcome (FR, joint count, duration of disease).
No takes yet. Share an insight, caveat, or question.
Erre et al. (2011) conducted a review in Rheumatoid arthritis. Anti-CCP antibodies testing vs. Rheumatoid Factor (RF) was evaluated. Anti-CCP antibodies demonstrate high specificity for diagnosing rheumatoid arthritis and may help predict disease persistence and radiographic joint damage, though their sensitivity in early arthritis remains debated.
Synapse has enriched 10 related papers. Consider them for comparative context: